The redox reaction of [Yb(C(9)H(7))(2)(thf)(2)] with the diazabutadiene PhN==C(Me)--C(Me)==NPh (DAD) has been found to depend on the molar ratio of the reactants. Reaction in a 1:2 molar ratio affords the dinuclear mixed-valent complex [Yb(2)(mu-eta(5):eta(4)-C(9)H(7))(eta(5)-C(9)H(7))(2){mu-eta(4):eta(4)-PhNC(Me)==C(Me)NPh}] containing an indenyl ligand with an unusual mu-eta(5):eta(4) bridging coordination. Reaction of equimolar amounts of these compounds results in an organolanthanide-mediated reductive coupling of the DAD ligands and formation of the tetranuclear mixed-valent complex [Yb(2)(mu-eta(5):eta(4)-C(9)H(7))(eta(5)-C(9)H(7))(2){mu-eta(4):eta(4)-PhNC(CH(2))==C(Me)NPh}](2) with a novel tetradentate tetraimine ligand.
No takes yet. Share an insight, caveat, or question.
Trifonov et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: